Minnesota Department of Health Tuberculosis Prevention and Control Program (651) Tuberculosis surveillance data for Minnesota are available
|
|
|
- Kenneth Butler
- 7 years ago
- Views:
Transcription
1 Minnesota Department of Health Tuberculosis Prevention and Control Program (651) Tuberculosis surveillance data for Minnesota are available on the Web at:
2 Year No. Cases Rate* * Cases per 100,000 population. Rates were calculated using state population estimates from the U.S. Census Bureau.
3
4 Percentage of Cases Year of Diagnosis
5
6 Year No. Cases No. Deaths* (%) (2%) (7%) (2%) (1%) (2%) *Represents only deaths due to TB disease or TB drug-induced toxicity
7 Location of Residence 2010 No. (rate)* 2011 No. (rate)* 2012 No. (rate)* 2013 No. (rate)* 2014 No. (rate)* Hennepin County 67 (5.8) 59 (5.0) 71 (6.1) 51 (4.3) 51 (4.3) Ramsey County 34 (6.7) 31 (6.0) 39 (7.6) 39 (7.5) 26 (4.9) Suburban Twin Cities Metro 16 (1.3) 12 (0.7) 27 (2.2) 20 (1.6) 24 (2.0) Olmsted County 6 (4.2) 9 (6.2) 3 (2.1) 10 (6.8) 16 (10.7) Other counties 12 (0.5) 26 (1.1) 22 (1.0) 31 (1.3) 30 (1.3) Total 135 (2.5) 137 (2.6) 162 (3.0) 151 (2.8) 147 (2.7) * Rate per 100,000 population. Rates were calculated using population estimates from U.S. Census Bureau data. Anoka, Carver, Dakota, Scott, and Washington counties
8 Location of Residence 2010 No. (rate)* 2011 No. (rate)* 2012 No. (rate)* 2013 No. (rate)* 2014 No. (rate)* Hennepin County 67 (50) 59 (43) 71 (44) 51 (34) 51 (35) Ramsey County 34 (25) 31 (22) 39 (24) 39 (26) 26 (18) Suburban Twin Cities Metro 16 (12) 12 ( 9) 27 (17) 20 (13) 24 (16) Olmsted County 6 ( 4) 9 ( 7) 3 ( 2) 10 ( 7) 16 (11) Other counties 12 ( 9) 26 (19) 22 (13) 31 (21) 30 (20) Total 135 (100) 137 (100) 162 (100) 151 (100) 147 (100) * Rate per 100,000 population. Rates were calculated using population estimates from U.S. Census Bureau data. Anoka, Carver, Dakota, Scott, and Washington counties
9 Hennepin: 51 Ramsey: 26 Suburban metro: 24 Greater MN: 46 Total: 147
10 Hennepin: 299 Ramsey: 169 Suburban metro: 99 Greater MN: 165 Total: 732
11 Percentage of Cases Place of Birth
12 N = 732
13 Cases per 100,000 * Race categories do not include persons of Hispanic/Latino origin. Rates were calculated using population estimates from the U.S. Census Bureau. ** The 2014 patient with multiple races is not represented in this graph.
14 Race / Ethnicity* Foreign-Born Cases No. (%) U.S.-Born Cases No. (%) White 15 (2) 59 (42) Black 308 (52) 35 (25) Asian 211 (36) 14 (10) Native American / Alaska Native 0 17 (12) Multi-racial 0 1 (<1) Hispanic/Latino 59 (10) 13 (9) Total 593 (100) 139 (100) *Race categories do not include persons of Hispanic/Latino origin. Includes U.S.-born children of foreign-born parents
15
16 Risk Category* 2010 (N=135) No. (%) 2011 (N=137) No. (%) 2012 (N=162) No. (%) 2013 (N=151) No. (%) 2014 (N=147) No. (%) Cumulative (N=732) No. (%) Foreign-born 110 (81) 116 (85) 136 (84) 123 (81) 108 (73) 593 (81) Substance abuse 7 (5) 7 (5) 7 (4) 9 (6) 7 (5) 37 (5) Homeless 3 (2) 2 (1) 2 (1) 4 (3) 7 (5) 18 (2) HIV-infected 6 (4) 3 (2) 6 (4) 4 (3) 4 (3) 23 (3) Other medical condition** 23 (17) 27 (20) 20 (12) 35 (23) 37 (25) 142 (19) Incarcerated 4 (3) 2 (1) 0 (0) 0 (0) 1 (1) 7 (1) Long-term care resident 3 (2) 2 (1) 1 (1) 2 (1) 0 (0) 8 (1) * Risk categories are not mutually exclusive Alcohol abuse and/or illicit drug use ** Conditions or therapies that increase risk for progression from latent TB infection to active TB disease, not including HIV/AIDS
17 N=732 * Risk categories are not mutually exclusive Alcohol abuse and/or illicit drug use ** Conditions or therapies that increase risk for progression from latent TB infection to active TB disease, not including HIV/AIDS
18 Cases (N=732) Medical conditions** No. (%) Diabetes 81 (11) End stage renal disease 19 (3) Weight loss/undernutrition/malabsorption 6 (1) Other: silicosis, hematologic disease 3 (<1) Other immunosuppressive condition or immunosuppressive therapy*** 56 (8) *Conditions or therapies that increase risk for progression from latent TB infection to active TB disease, not including HIV/AIDS **Patients could have > 1 medical condition ***Includes TNF α antagonist therapy and post-organ transplantation
19 * Risk categories are not mutually exclusive ** Conditions or therapies risk for progression to active TB disease, not HIV Alcohol abuse and/or illicit drug use
20 HIV Status Foreign-Born Cases No. (%) U.S.-Born Cases No. (%) Total No. (%) Negative 546 (92) 126 (91) 672 (92) Positive 21 (4) 2 (1) 23 (3) Refused 4 (1) 2 (1) 6 (1) Not Offered 22 (4) 9 (6) 31 (4) Total 593 (100) 139 (100) 732 (100)
21 Percent co-infected No. of TB- HIV cases in MN:
22 No. of eligible TB cases* Percent of eligible TB cases with HIV result * Alive at diagnosis
23 School/Setting No. (%) Preschool 2 (<1) Elementary 36 (5) Secondary 31 (4) Post-secondary 51 (7) Other* 52 (7) None 560 (77) Total 732 (100) *Includes: daycare, ESL/ELL, and other schools
24 Number of Cases Year * Other includes: Eastern Europe, North Africa/Middle East, and Western Europe
25 Number of Cases Region of Birth * Other includes: Eastern Europe, North Africa/Middle East, and Western Europe
26 N = 593
27 N = 593
28 * Per results of pre-immigration screening performed overseas N = 71
29 N = 593
30 % of foreign-born cases N = Technical instructions for overseas exams revised
31 N = 732
32 * Includes cases with or without concurrent pulmonary disease
33 Site of disease** Cases (N=356) No. (%) Lymphatic 192 (54) Musculoskeletal 51 (14) Pleural 40 (11) Peritoneal 22 (6) Genitourinary 14 (4) Brain 14 (4) Meningeal 11 (3) Other 26 (7) * Includes TB cases with or without concurrent pulmonary disease ** Patients may have multiple extrapulmonary sites of disease
34 N = 460 * From initial chest x-ray or chest CT scan
35 N = 460 *53% of pulmonary cases without sputum smear results were under 15 years of age
36 N = 732
37 N = 732 *Based on the public health surveillance definition for TB [CDC. (2009, June) CDC Tuberculosis Surveillance Data Training: Report of Verified Case of Tuberculosis (RVCT) Instruction Manual. Atlanta, GA: U.S. Department of Health and Human Services, CDC. (Appendix A - Tuberculosis Case Definition for Public Health Surveillance)]
38 Year Cases With Susceptibility Results* Any Drug Resistance No. (%) INH- Resistant** No. (%) MDR-TB No. (%) (12) 5 (5) 0 (0) (22) 12 (12) 3 (3) (19) 12 (10) 1 (1) (21) 13 (21) 0 (0) (24) 19 (18) 1 (1) Total (19) 61 (11) 5 (1) * Culture-confirmed cases with drug susceptibility results available Resistance to at least one first-line anti-tb drug [i.e., isoniazid (INH), rifampin, pyrazinamide (PZA), or ethambutol] ** INH-resistant cases may also be resistant to other drugs Multi-drug resistant TB, defined as resistance to at least INH and rifampin
39 Place of birth Cases With Susceptibility Results* Any Drug Resistance No. (%) INH- Resistant** No. (%) MDR-TB No. (%) Foreign-Born Cases (21) 53 (12) 4 (1) U.S.-Born Cases (14) 8 (8) 1 (1) Total (19) 61 (11) 5 (1) * Culture-confirmed cases with drug susceptibility results available Resistance to at least one first-line anti-tb drug [i.e., isoniazid (INH), rifampin, pyrazinamide (PZA), or ethambutol] ** INH-resistant cases may also be resistant to other drugs Multi-drug resistant TB, defined as resistance to at least INH and rifampin
40 N = 732 Overseas TB class follow-up 2% * Other includes: other immigration exam 1.3%, and employment screening (including health care worker screening) 1.6%
41 90%
42 90% Type of provider N=722 started on treatment * DOT = Directly Observed Therapy
43 Year Started Treatment* Completed Within 12 mos.** No. (%) Completed Overall** No. (%) (91) 115 (99) (95) 97 (96) (95) 130 (98) (93) 123 (98) Total (93) 465 (98) * Patients for whom < 12 months of therapy is indicated. This excludes: patients with rifampin resistance, meningeal TB, TB in bone or skeletal system, TB in CNS, children 14 years of age or younger with disseminated TB, patients who died or moved out of US within 366 days of starting treatment. ** Treatment completion data as of 9/14/2015
44 * Some patients are managed by multiple providers throughout disease course
Chapter 1 Overview of Tuberculosis Epidemiology in the United States
Chapter 1 Overview of Tuberculosis Epidemiology in the United States Table of Contents Chapter Objectives.... 1 Progress Toward TB Elimination in the United States.... 3 TB Disease Trends in the United
Population Percent C.I. All Hennepin County adults aged 18 and older 11.9% ± 1.1
Overview ` Why Is This Indicator Important? Physical inactivity can lead to obesity and type 2 diabetes. Physical activity can help control weight, reduce the risk of heart disease and some cancers, strengthen
TB Prevention, Diagnosis and Treatment. Accelerating advocacy on TB/HIV 15th July, Vienna
TB Prevention, Diagnosis and Treatment Accelerating advocacy on TB/HIV 15th July, Vienna Diagnosis Microscopy of specially stained sputum is the main test for diagnosing TB (1 2 days) TB bacilli seen in
Recent Advances in The Treatment of Mycobacterium Tuberculosis
Recent Advances in The Treatment of Mycobacterium Tuberculosis Dr Mohd Arif Mohd Zim Senior Lecturer & Respiratory Physician Faculty of Medicine, Universiti Teknologi MARA mohdarif035@salam.uitm.edu.my
Tuberculosis in Children and Adolescents
Tuberculosis in Children and Adolescents Ritu Banerjee, MD, Ph.D TB Clinical Intensive April 8, 2015 2014 MFMER slide-1 Disclosures None 2014 MFMER slide-2 Objectives Describe the epidemiology of pediatric
Self-Study Modules on Tuberculosis
Self-Study Modules on Tuberculosis Epidemiology of Tuberculosis U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for HIV/AIDS, Viral Hepatitis, STD,
Self-Study Modules on Tuberculosis
Self-Study Modules on Tuberculosis Treatment of Latent Tuberculosis Infection and Tube rc ulos is Disease U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National
Pediatric Latent TB Diagnosis and Treatment
Date Updated: April 2015 Guidelines Reviewed: 1. CDC Latent TB Guidelines 2. Harborview Pediatric Clinic Latent TB Management, 2010 3. Pediatric Associates Latent TB Guidelines, 2013 4. Seattle Children
Use of Nucleic Acid Amplification Tests in TB patients in California 2010-2012
Use of Nucleic Acid Amplification Tests in TB patients in California 2010-2012 Lisa Pascopella, PhD, MPH Pennan Barry, MD, MPH Tuberculosis Control Branch, Division of Communicable Disease Control, Center
MANAGEMENT OF TUBERCULOSIS
MANAGEMENT OF TUBERCULOSIS Dean B. Ellithorpe, M.D. Clinical Professor of Medicine Section of Pulmonary Diseases, Critical Care and Environmental Medicine Tulane University School of Medicine INTRODUCTION
TUBERCULOSIS SCREENING AND TREATMENT IN PREGNANCY. Stephanie N. Lin MD 2/12/2016
TUBERCULOSIS SCREENING AND TREATMENT IN PREGNANCY Stephanie N. Lin MD 2/12/2016 Epidemiology of TB 9.6 million new cases in 2014 12% of them are in HIV positive patients 1.5 million deaths in 2014 ~646
Impact of Diabetes on Treatment Outcomes among Maryland Tuberculosis Cases, 2004-2005. Tania Tang PHASE Symposium May 12, 2007
Impact of Diabetes on Treatment Outcomes among Maryland Tuberculosis Cases, 2004-2005 Tania Tang PHASE Symposium May 12, 2007 Presentation Outline Background Research Questions Methods Results Discussion
Abstract. 1. Basic underlying view
_ Abstract 1. Basic underlying view Mycobacterium tuberculosis Table 1 2. LTBI treatment subjects 1. Basic view 2. TB development risk factors and infection diagnosis i. HIV/AIDS ii. Hemodialysis for
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Centers for Disease Control and Prevention
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Centers for Disease Control and Prevention National Center for HIV, STD, and TB Prevention Division of Tuberculosis Elimination Public
Questions and Answers About Tuberculosis
Questions and Answers About Tuberculosis 2014 Questions and Answers About Tuberculosis 2014 Questions and Answers About Tuberculosis ( TB) was written to provide information on the diagnosis and treatment
Tuberculosis in children in Europe -the ptbnet
Tuberculosis in children in Europe -the ptbnet Beate Kampmann FRCPCH PhD A/Professor in Paediatric Infection & Immunity Consultant Paediatrician Imperial College London, UK and Institute of Infectious
Challenges in Pediatric Tuberculosis. Mimi Emig, MD Spectrum Health Kent County Health Department
Challenges in Pediatric Tuberculosis Mimi Emig, MD Spectrum Health Kent County Health Department Pediatric Tuberculosis: A Missed Public Health Opportunity Mimi Emig, MD Spectrum Health Kent County Health
Elisabeth Patton, DVM, PhD, Diplomate ACVIM
Brian Odegaard, RN BSN Public Health Madison & Dane County Diana Haley, RN BSN Sauk County Health Department Elisabeth Patton, DVM, PhD, Diplomate ACVIM Veterinary Program Manager Wisconsin Department
Tuberculosis and You A Guide to Tuberculosis Treatment and Services
Tuberculosis and You A Guide to Tuberculosis Treatment and Services Tuberculosis (TB) is a serious disease that can damage the lungs or other parts of the body like the brain, kidneys or spine. There are
MODULE THREE TB Treatment. Treatment Action Group TB/HIV Advocacy Toolkit
MODULE THREE TB Treatment Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be covered TB treatment fundamentals Treatment of TB infection and disease TB treatment research Advocacy issues 2 Section
Introduction to TB Nurse Case Management Online February 4, 11, 18 and 25, 2015
Introduction to TB Nurse Case Management Online February 4, 11, 18 and 25, 2015 Completion of Treatment: Case Studies or A Little Bit of Everything Presented by Cherie Fulk February 25, 2015 Cherie Fulk
Philadelphia TB Newsletter
Philadelphia Department of Public Health Philadelphia TB Newsletter Volume 6, 6, Issue Issue 1 1 WORLD TB DAY EDITION Spring 2012 500 S. Broad Street, 2nd Floor Philadelphia, PA 19146 Michael Nutter Mayor
Pregnancy and Tuberculosis. Information for clinicians
Pregnancy and Tuberculosis Information for clinicians When to suspect Tuberculosis (TB)? Who is at risk of TB during pregnancy? Recent research suggests that new mothers are at an increased risk of TB
San Francisco Treatment Guidelines for Latent Tuberculosis Infection
City and County of San Francisco Department of Public Health Tuberculosis Control Unit Julie Higashi, MD, PhD Director Population Health Division Edwin M. Lee Mayor Disease Prevention and Control Branch
Table. Positive Purified Protein Derivative Results (Pediatrics In Review Apr 2008)
PPD and TB Sreening COMPETENCY- The resident should know the risk factors for TB exposure, when to screen, and the appropriate criteria for recognizing a positive PPD in children of different age groups
Maria Dalbey RN. BSN, MA, MBA March 17 th, 2015
Maria Dalbey RN. BSN, MA, MBA March 17 th, 2015 2 Objectives Participants will be able to : Understand the Pathogenesis of Tuberculosis (TB) Identify the Goals of Public Health for TB Identify Hierarchy
X-Plain Pediatric Tuberculosis Reference Summary
X-Plain Pediatric Tuberculosis Reference Summary Introduction Tuberculosis, or TB, is a bacterial infection that causes more deaths in the world than any other infectious disease. When a child gets TB,
Targeted Testing and Treatment of Latent Tuberculosis Infection in Adults and Children
C D H S / C T C A J O I N T G U I D E L I N E S Targeted Testing and Treatment of Latent Tuberculosis Infection in Adults and Children Targeted Skin Testing and Treatment of Latent Tuberculosis Infection
Hepatitis C Virus Infection: Prevalence Report, 2003 Data Source: Minnesota Department of Health HCV Surveillance System
Hepatitis C Virus Infection: Prevalence Report, 2003 Data Source: Minnesota Department of Health HCV Surveillance System P.O. Box 9441 Minneapolis, MN 55440-9441 612-676-5414, 1-877-676-5414 www.health.state.mn.us/immunize
Tuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University
Tuberculosis And Diabetes Dr. hanan abuelrus Prof.of internal medicine Assiut University TUBERCULOSIS FACTS More than 9 million people fall sick with tuberculosis (TB) every year. Over 1.5 million die
You. guide to tuberculosis treatment and services
Adapted from TB and You: A Guide to Tuberculosis Treatment and Services with permission from Division of Public Health TB Control Program State of North Carolina Department of Health and Human Services
12 Points of Tuberculosis (TB) Patient Education
12 Points of Tuberculosis (TB) Patient Education Transmission of TB TB is a disease caused by the TB germ. The disease is mainly in the lungs (pulmonary TB), but the germ can travel to other parts of the
Massachusetts Department of Public Health Division of Global Populations and Infectious Disease Prevention
Massachusetts Department of Public Health Division of Global Populations and Infectious Disease Prevention Screening Infants and Children for Tuberculosis in Massachusetts Executive Summary In Massachusetts,
Chapter 5 Treatment for Latent Tuberculosis Infection
Chapter 5 Treatment for Latent Tuberculosis Infection Table of Contents Chapter Objectives.... 109 Introduction.... 111 Candidates for the Treatment of LTBI.... 112 LTBI Treatment Regimens.... 118 LTBI
Tuberculosis Prevention and Control Protocol, 2008
Tuberculosis Prevention and Control Protocol, 2008 Preamble The Ontario Public Health Standards (OPHS) are published by the Minister of Health and Long- Term Care under the authority of the Health Protection
Chapter 6 Treatment of Tuberculosis Disease
Chapter 6 Treatment of Tuberculosis Disease Table of Contents Chapter Objectives.... 139 Introduction.... 141 Treatment and Monitoring Plan.... 143 Adherence Strategies... 143 TB Disease Treatment Regimens....
Tuberculosis Exposure Control Plan for Low Risk Dental Offices
Tuberculosis Exposure Control Plan for Low Risk Dental Offices A. BACKGROUND According to the CDC, approximately one-third of the world s population, almost two billion people, are infected with tuberculosis.
New York City Department of Health Protocols for Latent TB Infection Treatment
New York City Department of Health Protocols for Latent TB Infection Treatment CONTENT A. Medical evaluation for latent TB infection (LTBI) treatment 1. Medical history and physical examination 2. Chest
TB in Refugees and Immigrants. Dora Marrufo, RN, BSN Delphina Sánchez, MA March 17, 2015
TB in Refugees and Immigrants Dora Marrufo, RN, BSN Delphina Sánchez, MA March 17, 2015 TB Nurse Case Management March 17 19, 2015 San Antonio, Texas EXCELLENCE EXPERTISE INNOVATION Dora Marrufo, RN, BSN
Tuberculosis. Subject. Goal/Objective. Instructions. Rationale. Operations Directorate, Health Branch Immigration Medical Examination Instructions
Subject Instructions for the screening of clients to detect tuberculosis (TB) in the context of the Canadian immigration medical examination (IME). Goal/Objective These instructions are provided to ensure
TUBERCULOSIS (TB) CASE MANAGEMENT/TEAM APPROACH. I. TITLE: Protocol for the case management of persons with suspected or confirmed active TB disease.
REVISED (original 4/93) TUBERCULOSIS (TB) CASE MANAGEMENT/TEAM APPROACH I. TITLE: Protocol for the case management of persons with suspected or confirmed active TB disease. II. TYPE OF STANDARD: Service
Clinical description 2 Laboratory test for diagnosis 3. Incubation period 4 Mode of transmission 4 Period of communicability 4
Tuberculosis Contents Epidemiology in New Zealand 2 Case definition 2 Clinical description 2 Laboratory test for diagnosis 3 Case classification 3 Spread of infection 4 Incubation period 4 Mode of transmission
Revised National Tuberculosis Control Programme (RNTCP) Dr. NAVPREET
Revised National Tuberculosis Control Programme (RNTCP) Dr. NAVPREET Assistant Prof., Deptt. of Community Medicine GMCH Chandigarh Problem Statement of TB in India India accounts for nearly 1/4 th of global
LEARNING OUTCOMES. Identify children at risk of developing TB disease. Correctly manage and refer children suspected of TB. Manage child contacts
TB in Children 1a TB IN CHILDREN 2 LEARNING OUTCOMES Identify children at risk of developing TB disease Correctly manage and refer children suspected of TB Manage child contacts 3 TB Infection and Disease
General Information on Tuberculosis
General Information on Tuberculosis ON THE MOVE AGAINST TUBERCULOSIS: Transforming the fi ght towards elimination World TB Day 2011 SAARC Tuberculosis & HIV/AIDS Centre GPO Box No 9517, Kathmandu, Nepal
2011 NTP Paediatric guidelines update- final draft
Childhood TB Investigation and management of children suspected to have tuberculosis (TB) or who are close contacts of a TB case (sputum smear positive or negative) Key facts Children who are close contacts
MANAGEMENT OF TUBERCULOSIS IN PRISONS: Guidance for prison healthcare teams
MANAGEMENT OF TUBERCULOSIS IN PRISONS: Guidance for prison healthcare teams Document control Title Type Author/s Management of tuberculosis in prisons: Guidance for prison healthcare teams Operational
Patient Education CONTENTS. Introduction... 12.2
CONTENTS Introduction... 12.2 Purpose... 12.2 General Guidelines... 12.3 Language and Comprehension Barriers... 12.4 Education Topics... 12.5 Medical Diagnosis... 12.5 Contact Investigation... 12.6 Isolation...
PEDIATRIC TUBERCULOSIS. Hot topics / Unresolved issues in Clinical Practice
PEDIATRIC TUBERCULOSIS Hot topics / Unresolved issues in Clinical Practice Ann M. Loeffler, M.D. Legacy Emanuel Children s Hospital Portland, OR Faculty Consultant Francis J. Curry National TB Center February
Santa Clara County Tuberculosis Screening Requirement for School Entrance Effective June 1, 2014. Frequently Asked Questions
Frequently Asked Questions A child has history of BCG vaccination, should they have TST or IGRA? According to the American Academy of Pediatrics Red Book (2012), Interferon Gamma Release Assay (IGRA) is
Massachusetts Tuberculosis Nursing Case Management Protocols. Tuberculosis Elimination Achieved through Management
Massachusetts Tuberculosis Nursing Case Management Protocols Tuberculosis Elimination Achieved through Management TABLE OF CONTENTS Page I. Introduction Theoretical Framework 5 5 Goal of Case Management
Chapter Four: Treatment of Tuberculosis Disease
Chapter Four: Treatment of Tuberculosis Disease The standard of tuberculosis (TB) treatment in Los Angeles County (LAC) is to initiate an appropriate chemotherapeutic regimen along with Directly Observed
TUBERCULOSIS (TB) SCREENING GUIDELINES FOR RESIDENTIAL FACILITIES AND DRUG
TUBERCULOSIS (TB) SCREENING GUIDELINES FOR RESIDENTIAL FACILITIES AND DRUG Tx CENTERS Tuberculosis Control Program Health and Human Services Agency San Diego County INTRODUCTION Reducing TB disease requires
Treatment of TB a pharmacy perspective
Treatment of TB a pharmacy perspective Colm McDonald, Antimicrobial Stewardship Pharmacist (Acting) National TB Conference, St. James s Hospital 6 th May 2011 Overview of presentation Role of the pharmacist
Tuberculosis (TB) Screening Guidelines for Substance Use Disorder Treatment Programs in California
Tuberculosis (TB) Screening Guidelines for Substance Use Disorder Treatment Programs in California 1 of 7 Table of Contents Preface 2 TB Symptoms and TB History 2 Initial Screening 2 Follow-Up Screening
NOTICE OF PUBLIC HEARING REGARDING PROPOSED CHANGES IN HEALTH CARE SERVICES PROVIDED BY FRESNO COUNTY
NOTICE IS HEREBY GIVEN that a public hearing will commence on Tuesday, September 23, 2008, at 9:00 a.m. (subject to continuance on that date of the hearing) at the Fresno County Board of Supervisors Chambers,
April 22, 2015 Curry International Tuberculosis Center
Tools for TB Elimination: Early Case Finding and Prevention Determining Your High-Risk Groups: Using the Universal Risk Assessment Tool Wednesday, d Sacramento, California Mike Carson, MS Program Manager
Tuberculousmeningitis: what is the best treatment regimen?
Tuberculousmeningitis: what is the best treatment regimen? H S Schaaf Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University
Tuberculosis: FAQs. What is the difference between latent TB infection and TB disease?
Tuberculosis: FAQs What is TB disease? Tuberculosis (TB) is a disease caused by bacteria (germs) that are spread from person to person through the air. TB usually affects the lungs, but it can also affect
Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges
Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges John B. Kaneene, DVM, MPH, PhD University Distinguished Professor of Epidemiology Director, Center for Comparative Epidemiology
N Dakota State Cancer and How to Manage the Outbreak
TB Outbreak Among Off-reservation, Homeless Native Americans Dawn Tuckey, MPH Program Consultant Field Services Branch Division of Tuberculosis Elimination National Center for HIV/AIDS, Viral Hepatitis,
GUIDELINES FOR TUBERCULOSIS PREVENTIVE THERAPY AMONG HIV INFECTED INDIVIDUALS IN SOUTH AFRICA
GUIDELINES FOR TUBERCULOSIS PREVENTIVE THERAPY AMONG HIV INFECTED INDIVIDUALS IN SOUTH AFRICA 2010 1 TB prophylaxis GUIDELINES FOR TUBERCULOSIS PREVENTIVE THERAPY AMONG HIV INFECTED INDIVIDUALS Background
New Jersey Department of Health and Senior Services. Standards of Care for Tuberculosis Disease and Latent TB Infection
New Jersey Department of Health and Senior Services Standards of Care for Tuberculosis Disease and Latent TB Infection Tuberculosis Medical Advisory Board March 2007 Table of Contents Standard # 1: Diagnosis
Georgia HIV/AIDS Surveillance Summary. Data Through December 31, 2010
Georgia HIV/AIDS Surveillance Summary Data Through December 31, 2010 HIV/AIDS Epidemiology Section Division of Health Protection Georgia Department of Public Health Table of Contents Acknowledgements...
Key findings. New Americans and their families live throughout the region. New Americans Living in the Twin Cities Region Today.
1 New Americans Living in the Twin Cities Region Today December 2014 About the American Community Survey The American Community Survey (ACS) is a continuously collected survey administered by the U.S.
CDC TB Testing Guidelines and Recent Literature Update
Pocket Guide QuantiFERON -TB Gold CDC TB Testing Guidelines and Recent Literature Update Using IGRAs for TB screening in your patients June 2010 A full copy of the US Centers for Disease Control and Prevention
A Review of Rental Housing with Tax Credits
A Review of Rental Housing with Tax Credits A Review of Rental Housing with Tax Credits Contents Summer 2013 Contents Minnesota Housing Planning, Research & Evaluation CONTENTS Page Summary 1 Introduction
Performance Evaluation and Clinical Application of MTB NAAT in Orange County, CA. Minoo Ghajar Orange County Public Health Laboratory
Performance Evaluation and Clinical Application of MTB NAAT in Orange County, CA Minoo Ghajar Orange County Public Health Laboratory TB Case Count and Rate: Orange County, CA and the United States, 2012
Emerging Infectious Disease (4): Drug-Resistant Tuberculosis
S67 Drug-Resistant Tuberculosis Emerging Infectious Disease (4): Drug-Resistant Tuberculosis Chi-Fang You, MD; Han-Ping Ma, MD; Tzong-Luen Wang, MD, PhD; Aming Chor-Min Lin, MD Abstract Before the discovery
Tuberculosis and Diabetes
Tuberculosis and Diabetes Eric R. Houpt MD, Professor, Division of Infectious Diseases Int l Health University of Virginia Scott Heysell MD Jane Moore VDH No disclosures Overview Diabetes increases the
Tuberculosis: Illness, Treatment, Lifestyle. Patrick J. Brennan, M.D University of Pennsylvania
Tuberculosis: Illness, Treatment, Lifestyle Patrick J. Brennan, M.D University of Pennsylvania Dedication To the patients who inspired this project and instill it with meaning. Acknowledgments This project
Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care
Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care Anna Satcher Johnson, MPH Symposium on Measuring the HIV Care Continuum Center for AIDS Research University of Washington
Age In London TB is more common in younger adults aged 15-44 years and peaks in the 25-34 age group (3).
4. TUBERCULOSIS INTRODUCTION Tuberculosis (TB) is an infectious, notifiable disease (meaning there is a requirement by law to report it to government authorities) caused by the bacterium Mycobacterium
With Depression Without Depression 8.0% 1.8% Alcohol Disorder Drug Disorder Alcohol or Drug Disorder
Minnesota Adults with Co-Occurring Substance Use and Mental Health Disorders By Eunkyung Park, Ph.D. Performance Measurement and Quality Improvement May 2006 In Brief Approximately 16% of Minnesota adults
Recommendations from the Minnesota Department of Health (MDH) for Completing the CDC Facility TB Risk Assessment Worksheet
Recommendations from the Minnesota Department of Health (MDH) for Completing the CDC Facility TB Risk Assessment Worksheet The Facility TB Risk Assessment Worksheet, developed by the Centers for Disease
Refugee Health Screening in MN
Refugee Health Screening in MN Federal Refugee Act of 1980 Exam w/in the first 90 days of arrival Public health clinics and private providers Goal:...to control communicable disease among, and resulting
MANAGEMENT OF COMMON SIDE EFFECTS of INH (Isoniazid), RIF (Rifampin), PZA (Pyrazinamide), and EMB (Ethambutol)
MANAGEMENT OF COMMON SIDE EFFECTS of INH (Isoniazid), RIF (Rifampin), PZA (Pyrazinamide), and EMB (Ethambutol) 1. Hepatotoxicity: In Active TB Disease a. Background: 1. Among the 4 standard anti-tb drugs,
Pregnancy and Tuberculosis. Patient and Public information sheet
Pregnancy and Tuberculosis Patient and Public information sheet Who is at risk of TB? Anyone can catch TB, but it is possible that pregnant women have a slightly higher risk of TB. Some people are more
Treatment completion is an
Treatment Episode Data Set The TEDS Report Treatment Outcomes among Clients Discharged from Residential Substance Abuse Treatment: 2005 In Brief In 2005, clients discharged from shortterm were more likely
Primary Care Management of Latent Tuberculosis Infection in the Foreign-Born
Primary Care Management of Latent Tuberculosis Infection in the Foreign-Born Investigators Carey Jackson MD, MPH University of Washington Jenny Pang MD, MPH, Seattle-King County Department of Public Health
San Francisco Guidelines on the Use of QuantiFERON-TB Gold (In Tube Method) for the Diagnosis of Latent TB Infection
San Francisco Guidelines on the Use of QuantiFERON-TB Gold (In Tube Method) for the Diagnosis of Latent TB Infection Rationale When to Screen for TB Choosing the Right TB Test Patient Registration Pre-Test
Alabama s Rural and Urban Counties
Selected Indicators of Health Status in Alabama Alabama s Rural and Urban Counties Jointly produced to assist those seeking to improve health care in rural Alabama by The Office of Primary Care and Rural
Treatment of Patients with Drug Addiction and Tuberculosis: New Strategies for the Future Directions
Treatment of Patients with Drug Addiction and Tuberculosis: New Strategies for the Future Directions Iván D. Montoya, M.D., M.P.H. Deputy Director, Division of Pharmacotherapies and Medical Consequences
Alabama Department of Public Health Bureau of Communicable Disease Division of TB Control
Alabama Department of Public Health Bureau of Communicable Disease Division of TB Control Tuberculosis Elimination and Laboratory Cooperative Agreements Program Announcement Number: 05003 Catalogue of
Hepatitis C Infections in Oregon September 2014
Public Health Division Hepatitis C Infections in Oregon September 214 Chronic HCV in Oregon Since 25, when positive laboratory results for HCV infection became reportable in Oregon, 47,252 persons with
Tuberculosis Policy and Procedure Manual 2014
Tuberculosis Policy and Procedure Manual 2014 Georgia Department of Public Health Division of Health Protection Office of Immunization and Infectious Disease Tuberculosis Program http://dph.georgia.gov/tuberculosis-tb-prevention-and-control
Hawaii Administrative Rules. Title 11. Department of Health. Chapter 164. Tuberculosis
Hawaii Administrative Rules Title 11 Department of Health Chapter 164 Tuberculosis 11-164-1 Purpose 11-164-2 Definitions 11-164-3 Reports to the department 11-164-4 Content of report 11-164-5 Examination
Case Management Treatment Plan for Active TB Disease
Case Management Treatment Plan for Active TB Disease The purpose of this form is to provide a checklist to organize the gathering of information in a TB case to ensure the best medical and public health
DATA MANAGEMENT STRATEGIES IN COMPLEX INVESTIGATIONS
DATA MANAGEMENT STRATEGIES IN COMPLEX INVESTIGATIONS Kristy M. Bolen, MPA Senior Regional Epidemiologist May 7, 2013 OBJECTIVES Ways to manage data during a complex investigation Including data collection
The economic impact of Normandale Community College
The economic impact of Normandale Community College F E B R U A R Y 2 0 1 3 The economic impact of February 2013 Prepared by: Jose Y. Diaz and Gabriel Pina Wilder Research 451 Lexington Parkway North Saint
New York State s Racial, Ethnic, and Underserved Populations. Demographic Indicators
New York State s Racial, Ethnic, and Underserved Populations While much progress has been made to improve the health of racial and ethnic populations, and increase access to care, many still experience
Nevada State Health Division Technical Bulletin
Nevada State Health Division Technical Bulletin Topic: Using QuantiFERON and Tuberculin Skin Test to Screen for TB Section/Program/Contact: Bureau of Community Health / Tuberculosis Program / Susanne Paulson,
Race and Ethnicity. Racial and Ethnic Characteristics for Bellevue
The Census contains a great deal of information that outlines the increasing level of diversity in our community. Among the demographic trends outlined in this section of the report will be race, ethnicity,
TB preventive therapy in children. Introduction
TB preventive therapy in children H S Schaaf Department of Paediatrics and Child Health, and Desmond Tutu TB Centre Stellenbosch University, and Tygerberg Children s Hospital Introduction Children are
Y O U T H L E A D. Summer U LEAD Program Application
Summer U LEAD Program Application Y O U T H L E A D U LEAD is sponsoring a summer job program for Ramsey County Suburban youth ages 14 to 24. Youth must complete the summer application and complete work
2012 (#): (0121) 2012-1 2 3 4 SFY
Provider Name (#): Locust Street Resource Center (0121) Date of Report: 09/30/2012 Engagement, Retention and Continuity of Care Measure Status by Level of Care and SFY 2012 Quarter* Level I - Engagement
Management of Tuberculosis
Federal Bureau of Prisons Clinical Practice Guidelines January 2010 Clinical guidelines are being made available to the public for informational purposes only. The Federal Bureau of Prisons (BOP) does
Minnesota HIV/AIDS Epidemiologic Profile
Minnesota HIV/AIDS Epidemiologic Profile DECEMBER 2015 Executive Summary Abbreviations Used AIDS Acquired Immune Deficiency Syndrome ADAP AIDS Drugs Assistance Program CCCHAP Community Cooperative Council
Staying on Track with TUBERCULOSIS. Medicine
Staying on Track with TB TUBERCULOSIS Medicine What s Inside: Read this brochure to learn about TB and what you can do to get healthy. Put it in a familiar place to pull out and read when you have questions.
Tuberculosis Coding and Billing Tool
Tuberculosis Coding and Billing Tool 2014 Georgia Department of Public Health Division of Health Protection Office of Immunization and Infectious Disease Tuberculosis Program http://dph.georgia.gov/tuberculosis-tb-prevention-and-control